East Shines Over West? US Rejection Puts Roxadustat's China Approval In New Spotlight

Japan, EU Offer Other Growth Alternatives?

 
• By Brian Yang
  
Blood cells
FIBROGEN'S ROXADUSTAT REJECTED IN US BUT CHINA, JAPAN, EU PRESENT OTHER OPPORTUNITIES • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia